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Abstract 
 
Background: As imaging centers produce higher resolution research scans, the number of man-
hours required to process regional data has become a major concern. Comparison of automated 
vs. manual methodology has not been reported for functional imaging. We explored validation of 
using automation to delineate regions of interest on positron emission tomography (PET) scans. 
The purpose of this study was to ascertain improvements in image processing time and 
reproducibility of a semi-automated brain region extraction (SABRE) method over manual 
delineation of regions of interest (ROIs). 
Methods: We compared 2 sets of partial volume corrected serotonin 1a receptor binding 
potentials (BPs) resulting from manual vs. semi-automated methods. BPs were obtained from 
subjects meeting consensus criteria for frontotemporal degeneration and from age- and gender-
matched healthy controls. Two trained raters provided each set of data to conduct comparisons of 
inter-rater mean image processing time, rank order of BPs for 9 PET scans, intra- and inter-rater 
intraclass correlation coefficients (ICC), repeatability coefficients (RC), percentages of the 
average parameter value (RM%), and effect sizes of either method. 
Results: SABRE saved approximately 3 hours of processing time per PET subject over manual 
delineation (p<.001). Quality of the SABRE BP results was preserved relative to the rank order 
of subjects by manual methods. Intra- and inter-rater ICC were high (>0.8) for both methods. RC 
and RM% were lower for the manual method across all ROIs, indicating less intra-rater variance 
across PET subjects’ BPs.  
Conclusions: SABRE demonstrated significant time savings and no significant difference in 
reproducibility over manual methods, justifying the use of SABRE in serotonin 1a receptor 
  
radioligand PET imaging analysis. This implies that semi-automated ROI delineation is a valid 
methodology for future PET imaging analysis. 
  
Background 
Advances in functional neuroimaging techniques have allowed the correlation of regions 
of interest (ROIs) with behavioral and cognitive tasks. Manual delineation of ROIs by trained 
operators is still considered the “gold standard,” given its precision for the targets; however some 
drawbacks of manual analysis have recently been pointed out, such as its labor-intensive 
requirements (i.e., extensive time needed for ROI drawing) [1], limited reproducibility [2], and 
difficulties in measuring cortical ROIs [3]. In order to resolve these problems, some researchers 
have suggested other methods of analysis as represented by an automated program to label brain 
regions [4], automated evaluation of the whole brain [5], and automated voxel-based 
morphometry [6]. Unfortunately, these alternatives also are limited by ROIs available [4, 5] and 
the potential inaccuracy introduced by spatial normalization of the brain [7]. The semiautomatic 
brain region extraction (SABRE) method was designed by Dade et al. to minimize the errors of 
both manual and automated analysis [1].  
 SABRE combines manual and automated analyses, which maximizes the advantages of 
both methods by manual definition of the most essential landmarks to create a customized atlas 
for the individual brain and automatic brain parcellation. SABRE has proven reliable in assessing 
regional tissue volume, and it provides time savings over purely manual methods.  
 The present study compares the benefits of the SABRE method to manual ROI 
delineation. We searched Pubmed for similar studies using the search terms: “automated brain 
region extraction,” “brain region extraction,” “manual ROI AND automated,” “region of interest 
delineation,” “SABRE,”  “semiautomated brain region extraction,” and “semiautomatic brain 
region extraction.” This yielded 491 citations. Of these, 5 described research questions similar to 
  
ours [8-11]. Three studies reported the effects of semi-automated methods vs. manual delineation 
methods for structural or volumetric MRI results for limited regions of brain such as 
hippocampus [10, 11] or ventricular cerebrospinal fluid volume [9]. One of the hippocampal 
studies required manual delineation on the subject’s first MRI, then used automated algorithms 
to gauge longitudinal volumetric changes from the original, individualized template [11]; the 
other hippocampal study used a novel expanding seed voxel with constraint points to identify 3D 
volumes of interest from the inside out [10]. Mosconi et al. validated automated voxel-based 
FDG-PET analysis including spatial normalization of hippocampal probability ROIs [12]. Only 
Mega et al. described a parcellation of brain into cortical regions as SABRE does [8]. Their 
sample also included subjects with cortical atrophy due to neurodenegerative processes but the 
imaging process requires warping to a standardized volumetric brainspace. Studies comparing 
ROI extraction reported positive conclusions in favor of using automation to save time [8, 10, 
11] or achieving similar accuracy to manual methods [8-11], but none of them have validated the 
use of semi-automated methods to process functional imaging data or to process multiple cortical 
regions without warping. 
This study is a first time application of SABRE to a positron emission tomography (PET) 
study of patients with frontotemporal degeneration (FTD). As PET scanners evolve to yield 
larger numbers of image slices, the man-hours required to delineate ROIs for each subject 
become impractical. We wished to validate the use of SABRE in analyzing our PET data. 
Assuming that manual analysis is the gold standard, we compared the PET results generated by 
manual ROI drawing to those by SABRE, on the bases of analysis time, effect of analysis 
method on PET results, reproducibility, and ability to discriminate FTD patients from healthy 
control subjects. We hypothesized that SABRE would save image processing time without 
  
altering the basic quality of PET results but that SABRE would be less sensitive to detect the 
differences between an FTD patient group and an age-matched healthy comparison group. We 
also hypothesized that SABRE’s test-retest reproducibility would be superior to the manual 
method, which might compensate for any loss of sensitivity. Balancing these characteristics 
might allow investigators to choose the more feasible and statistically useful procedure for future 
PET analyses of an FTD population. 
 
Methods 
Participants 
 We used data from 9 participants in a study comparing serotonin 1a receptor (5-HT1aR) 
density as estimated by radioligand binding potentials (BPs) from PET imaging data [13]. We 
studied 5 patients with FTD diagnosed by consensus criteria [14], duration 3-6 years. They were 
1 man and 4 women, ages ranging 59-79 years, with MMSE scores 16-30, and CDR scores of 
0.5). We also studied 4 age- and gender-matched healthy comparison subjects (1 man and 3 
women, age range 63-80 years). The study procedures were reviewed and approved by Research 
Ethics Boards at all participating institutions. All 9 subjects or their substitute decision makers 
gave informed consent to participate in the study. 
MRI data acquisition 
Imaging procedures: We conducted structural MR imaging on a 1.5 T Signa research-
dedicated scanner (GE Medical Systems, software v. 8.4M4, with CV 40mT/m gradients) at 
Sunnybrook Health Sciences Centre.  We acquired a high-resolution T1-weighted image (an 
axial 3D SPGR with 5ms TE, 35ms TR, 1 NEX, 35
o
 flip angle, 22 x 16.5 cm FOV, 0.859 x 
  
0.859mm in-plane resolution, and 1.2 to 1.4mm slice thickness depending on head size).  This 
was followed by an interleaved proton density (PD) and T2-weighted image set (an interleaved 
axial spin echo with TEs of 30 and 80 ms, 3s TR, 0.5 NEX, 20 x 20cm FOV, 0.781 x 0.781mm 
in-plane resolution, and 3mm slice thickness).  The T1-weighted and PD/T2-weighted imaging 
parameters have been selected to provide optimal intensity separation and are routinely used for 
tissue segmentation [15]. 
Serotonin 1a receptor (5-HT1aR) PET acquisition 
 PET scans with the radioligand [
11
C]WAY-100635, a 5-HT1aR antagonist, were 
performed within 3 months of the MRI scans. Specific activity at time of intravenous injection of 
the radioligand averaged 793 + 373 mCi/µmol. PET images were acquired for 15 transaxial 
slices (slice thickness of 6.5mm) over 90 minutes with a GE Medical System PC-2048-15B 
camera with 5.5mm intrinsic resolution FWHM. 
 Co-registered MR and PET images were used for semi-automated and manual ROI 
delineation, as described below. 
Manual region of interest delineation 
 We co-registered T1 MR images to the summed PET frames with Rview software [16], 
then hand-drew ROIs manually on the co-registered T1 images with the Alice software 
(Perceptive Informatics, Waltham, Massachusetts), based on previously defined landmarks (refer 
to Appendix I, see Additional file 1) [17-22]. Based on the proximity to the SABRE ROIs, the 
following twelve manual ROIs were used to generate the TACs of brain uptake: frontal lobe, 
orbitofrontal cortex (OFC), dorsolateral prefrontal cortex (DLPFC), anterior lateral temporal lobe 
(ALT), and middle amygdala-anterior parahippocampus (medial temporal) (10 ROIs across both 
  
hemispheres). Two well-trained technicians, CP (Rater M1) and PSJ (Rater M2), hand-drew 
ROIs.      
Cortical atrophy challenges the accurate interpretation of functional images from patients 
with dementia. A partial volume correction (PVC) method has been adapted to correct WAY-
PET imaging resolution issues. The PVC algorithm corrects for atrophy, spill-in effects, and 
spill-out effects. This is a variation of the algorithm by Bencherif et al. [23], modified so that 
calculations are performed in higher-resolution MR space. The algorithm was used to create a 
map of gray matter (GM) vs. non-GM pixels for each subject. We then applied the hand-drawn 
ROIs to the map and used Alice
TM
 to calculate average correction factors for each ROI. We 
submitted the initially derived BPs to their corresponding correction factors and report here the 
corrected BPs.  
SABRE ROI delineation 
 The SABRE method uses a robust tissue segmentation protocol, which accounts for 
regional field (RF) inhomogeneities, noise, and partial volume effects [15]. When tested using 
the Montreal Neurological Imaging phantom, the coefficient of total agreement with increased 
noise and RF inhomogenity levels was 0.97. When tested on young normal controls and elderly 
Alzheimer's disease patients, the maximal differences were less than 1% of total intracranial 
capacity in all tissue classes in a scan-rescan test. 
The SABRE process begins with segmentation of the MRI data into GM, white matter, 
ventricular cerebral spinal fluid and subdural/sulcal CSF (ssCSF) [1, 15]. In fact, these 
segmentation data were used for the PVC algorithm described above. First, the operator 
subtracted the non-brain tissue (e.g., skull) from the T1 MR images to extract the T1 intracranial 
cavity (T1 eroded images). Identification of 15 landmarks on the 3D-rendered T1 images (e.g., 
  
anterior commissure (AC), central sulcus) with ANALYZE software (Biomedical Imaging 
Resource, Mayo Clinic, Rochester, Minnesota) yields a proportional Talairach grid of each 
individual’s eroded T1 images [1]. Using the resulting proportional grid and defined landmarks, 
the SABRE program parcellates the eroded T1 images automatically into 26 zones (13 in each 
hemisphere).  
To convert the SABRE zones into ROIs, we used AIR (version 5.5) to yield the optimal 
matrix for co-registration of the T1 masked images to the summed 0-90 minute PET frames (15 
transaxial slices) [24]. We restricted the SABRE zones to GM-only portions, outlining them 
automatically with ANALYZE, because SABRE zones must be converted from opaque square 
fields to ALICE-compatible outlines.  See figure 1 for an illustration of manual vs. SABRE-
generated outlines of ROIs. 
The same SABRE ROIs were applied to the grey matter vs. non-GM PET data map to 
derive SABRE-specific average correction factors for each ROI. These were then applied to the 
TAC data to derive the second set of partial volume corrected BPs for comparison to the manual 
ROI data. These procedures were performed by a neurosurgeon (ST, Rater S1) and a highly 
trained technician (JR, Rater S2). 
 Derivation of binding potential (BP) 
 Manual and SABRE ROIs became the overlays applied to the dynamic PET images to 
calculate BP values of each ROI with Alice and PKIN/PMOD software (PMOD group, Zürich, 
Switzerland) [25, 26]. A simplified reference tissue method (SRTM) was performed to obtain BP 
values, using the cerebellum as the input function [27], given previous findings that the 
cerebellum is relatively devoid of 5HT1aR [28] and that this method has been proven to be 
superior to kinetic modeling using arterial data [29]. 
  
Statistics 
 Because the BP itself is a relative estimation, and the SABRE regions are inexact proxies 
of the hand-drawn ROIs, we did not seek direct correlations between BPs from manual vs. 
SABRE ROIs. Instead, we compared the methods with regard to: 1) image processing time, 2) 
basic quality of PET results, 3) reproducibility of BP results, and 4) sensitivity to differentiate 
FTD patients from comparison subjects based on BP results.  
Manual raters (M1 and M2) and SABRE raters (S1 and S2) delineated ROIs on the 
imaging data a total of 6 times. Raters M1 and S1 repeated the process to yield the following sets 
of 5HT1aR BP values: M1A, M1B, M2; S1A, S1B, S2. 
 We averaged inter-rater processing times for each method (i.e., (M1A +M2)/2 and (S1A 
+S2)/2), then compared the mean time spent to process the data using either manual or SABRE 
methods with the unpaired Student’s t-test, as we expected SABRE to save time. 
   We evaluated the basic quality of PET results by calculating the over all rank order of 
BPs among 9 subjects in each ROI with the Spearman rank correlation test.  We calculated ratios 
of BPs in the left regions to those of the corresponding right regions (L/R ratios) for comparison 
of the two methods with the Wilcoxon signed rank test. 
 We assessed the reproducibility of the tested analysis methods based on intra- and inter-
rater reliability for the BPs. We rated intra-rater reliability using intraclass correlation 
coefficients (ICC), repeatability coefficients (RC), and percentages of the average parameter 
value (RM%, a measure of coefficient of variation of the difference between the methods). ICC 
were based on the 1
st
 and 2
nd
 results generated by the same rater (M1A vs. M1B and S1A vs. 
S1B). To determine RM%, we first calculated the RC as twice the standard deviation (SD) of the 
difference between the average BP values for each of the ROIs from the 1
st
 and 2
nd
 analyses (e.g., 
  
M1A and M1B), expecting 95% of the differences to be less than the RC [30]. In addition, to 
facilitate comparisons across regions, the RC was calculated as percentage of the mean BP to 
obtain the RM% [27]:  
( )
( )21
212
%
BPscanBPscanMean
BPscanBPscanSD
RM
+
−×
= x 100% 
 Inter-rater reliability was assessed by calculating ICC between manual results M1A vs. 
M2 and SABRE results from S1A vs. S2. We used SPSS: Analysis: Scale: Reliability: Statistics 
– ICC to make these calculations. We used the Wilcoxon signed rank test to compare the 
resulting average ICC for manual vs. SABRE results.  
Sensitivity to differentiate FTDs from controls 
 We used two indicators to assess the ability of the methods to differentiate FTD patients 
from healthy comparison subjects. At autopsy, FTD patients have significant reductions in 
serotonin receptor densities [31, 32]; we expected to find similar losses, reflected as lower BPs, 
during the course of illness. First we compared the mean BPs for each ROI with paired t-tests. 
We also defined Cohen’s measures for the effect size (d) as the average BP value for the FTD 
group minus that for comparison subjects divided by the standard deviation for the pooled 
samples [33]. We compared the calculated d values between manual and SABRE methods with 
the Wilcoxon signed rank test. 
We used SPSS (version 15.0, SPSS, Inc., Chicago, Illinois) for all statistical analyses. 
 
Results 
  
Table 1 shows the range of mean 5-HT1a R BP values. Mean BPs after partial volume 
correction were similar between manual and SABRE methods, without significant differences 
between FTD and control BPs. 
Imagine Processing Time 
 The image processing time for SABRE had statistically and practically significant 
savings over the manual method (p<0.0001): S1A/S2 1.2 ± .08 hours per subject vs. M1A/M2 5 
± 0.75 hours per subject; S1B/S2 1.2 ± .08 hours vs. M1B/M2 3.5 ± 0.3 hours. 
Basic quality of PET results 
 We found significant positive correlations between the rank order of BPs among the 9 
tested subjects in the majority of rater x method comparisons, but measurements for anterior 
lateral and medial temporal regions were less similar (see Table 2).  
In the comparison of L/R ratios of BPs, the orbitofrontal cortex (OFC) showed the 
highest average L/R ratio in both manual and SABRE results for all 6 raters’ measurements of 
BPs (see Table 3). One subject had a very small right OFC, which led to higher variance in both 
manual and SABRE measurements. When this subject’s data were excluded, the SABRE average 
for raters S1A, S1B, and S2 were more similar at 1.16, 1.15, and 1.13, respectively. Most L/R 
ratios were very close to 1.0. After excluding the outlier, there were no statistically significant 
Wilcoxon results. 
Reproducibility of BP results 
 SABRE methods achieved average intra-rater (S1A vs. S1B) ICC values similar to the 
manual methods (see Table 4), but Wilcoxon rank testing showed significant differences in 
average RC and RM%, supporting manual methods as more reliable when examining intra-rater 
performance. As shown in the table, the RM% had a wide range across ROIs. 
  
 SABRE results yielded high ICC values for inter-rater reliability in general (see Table 5). 
Average SABRE ICC ranged from 0.91 – 0.97 on both hemispheres, with lower ICC for DLPFC 
ROIs. Rater S2’s BP results for DLPFC from one control were exceptionally large (~9.5 vs. ~5). 
When the data for this subject were excluded, ICC for this ROI increased to 0.83, 0.79, 0.85, and 
0.85, reading left to right across Table 5.  
In comparison, ICC values for the manual method were slightly lower averages, ranging 
0.79 -0.87. As opposed to the DLPFC, the lowest ICC for the manual ratings were in the anterior 
lateral temporal lobe. No cross-method comparisons were statistically significantly different.  
Sensitivity to differentiate FTD patients from healthy comparison subjects 
 Average BP values of FTD patients did not differ from those of healthy comparison 
subjects according to the unpaired Student’s t-test, regardless of the method used to delineate 
ROIs. Cohen’s d values (effect sizes) for the SABRE method were higher than for the manual 
method across all ROIs (see Table 6). SABRE-derived d’s exceeded manually-derived d’s with p 
< 0.05, except in the comparison against rater M2. This particular finding supports the lower 
inter-rater reliability of the manual method. Effect sizes for left and right OFC were larger than 
for other ROIs. As in Table 3, the right OFC BP from one subject was thought to be an outlier. 
Values for right OFC effect sizes when this subject was excluded still varied greatly, reflecting 
the difficulty of measuring BP when the ROI is very small: M1A  0.24, M1B –0.19, M2 –0.28, 
S1A –0.37, S1B –0.39, and S2 –0.55.  
 
  
Discussion 
 Prior studies have shown that automated methods of ROI delineation can be accurate and 
time-saving for structural volumetric analyses [8-11]. Our present results indicate that the 
SABRE method also saves time for functional radioligand PET analysis without altering the 
basic quality of the results as compared to the gold standard, manual ROI analysis. Intra-rater 
ICC and reliability were greater for manual methods than SABRE, exceeding reliability criteria 
pegging acceptable ICC values at a range of 0.75-0.80 [34]. Inter-rater ICC also met acceptable 
ICC value criteria, with the exception of manual anterior lateral temporal ROIs. The inter-rater 
reproducibility of PET results using SABRE was at least as high as that using the manual 
method. Although SABRE failed to significantly discriminate FTD patients from healthy 
comparison subjects, which may be related to the small sample size, higher d values for SABRE 
imply that SABRE can detect the expected 5- HT1a R BP differences between FTD patients and 
comparison subjects more sensitively than manual analysis. 
The image processing time savings are amplified for datasets where more than 15 slices 
are available: compared to more current scanners that would afford 124 slices, our approximately 
3 hour difference between methods would translate to at least an 8-hour saving (2 hours for 
SABRE vs. at least a 10 hour manual task). 
Limitations of this study include low sample size and difficulty pinpointing the 
differences between methods specific to the manual vs. SABRE aspect. Ideally, a validation 
study would include a larger group of imaging data, as well as more inter-rater comparisons. 
Using a small number may bias our search for similarity of data quality in favor of SABRE.  A 
larger sample would make the analysis less vulnerable to outliers. Only Mega et al.’s study [8] 
  
included 20 subjects (more than twice our sample), consisting of both patients with 
neurodegenerative disease and controls. 
Inclusion of both subjects with moderate to severe cortical atrophy due to FTD and 
healthy controls with little or no atrophy may have compensated for the small sample size by 
creating a varied landscape over which both methods had to perform, but the atrophic ROIs may 
have complicated reproducibility of anterior lateral temporal, DLPFC, and right OFC 
delineation. A further important limitation is our method of correcting for partial volume effects, 
in which we applied correction factors to the regional BPs and not to the individual data points 
along the time activity curve (TAC). Our partial volume effect method suffices for the purpose of 
our comparison, but most investigators will perform partial volume effects compensation at an 
earlier data modeling step. 
 Differences between the methods may be related to aspects of image processing other 
than the actual delineation of the ROIs. We used Rview for co-registration of the MRI to the PET 
images for the manually derived data and AIR for the SABRE data. Software also differed for 
tracing the ROIs: manual raters used Alice; SABRE raters used ANALYZE. These software 
variations are difficult to include as covariates in the analysis and cannot be ruled out as 
confounders. It would be difficult to conceive of a significant impact of the software upon the 
time saved in image processing. 
The validation results reported here only apply to this specific experimental setup. It is 
not known how the accuracy of the procedure is affected by errors in MRI segmentation and/or 
MRI-PET coregistration, which differ when other radiotracers or segmentation and coregistration 
strategies are used. 
  
Our findings that SABRE saved time over manual drawing of multiple ROIs are not 
surprising; the most similar studies in the literature are in agreement [8-11]. Because structural 
landmarks are the bases of ROIs processed in the interpretation of PET images, it seemed 
consistent to find that reproducibility for the SABRE method was equivalent to manual methods. 
The SABRE method requires identification of fewer anatomical landmarks (15), as opposed to 
boundaries for each of 10 ROIs in the manual process (approximately 60 localizations, see 
Appendix) and therefore should leave less room for variation between raters. Ashton et al.’s 
valid concern about error due to the tracking between slices required from 2D techniques [10] 
could not be evaluated in our comparison, as derivation of data for the BP measurements uses 2D 
techniques and would therefore be exposed to the same types of edge detection limitations. 
 
Conclusion 
This first account of semi-automated ROI delineation improving on manual methods in 
processing functional neuroimaging data validates the use of SABRE for future PET studies 
where the analysis relies upon hypothesis-based inquiry of ROIs. Investigators are cautioned 
about the potential for reduced reliability using either method when studying ROIs featuring 
marked atrophy in patient subjects. 
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Figure Legends 
 
Figure 1. Region of interest delineation: a) manual, b) using SABRE. 
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Tables 
 
Table 1.  Average regional 5-HT1a receptor BP values 
  Manual 
  Patients Comparison Subjects 
 M1A M1B M2 M1A M1B M2 
  Lt Rt Lt Rt Lt Rt Lt Rt Lt Rt Lt Rt 
Frontal lobe 3.64 ± 1.89 3.57 ± 1.91 3.81 ± 2.11 3.71 ± 2.10 4.96 ± 2.07 4.96 ± 2.27 3.49 ± 0.93 3.47 ± 0.64 3.53 ± 0.86 3.47 ± 0.64 5.52 ± 1.46§ 4.98 ± 1.00 
OFC 5.01 ± 3.92 4.34 ± 4.35 4.89 ± 3.95 4.36 ± 4.47 5.62 ± 3.07 5.01 ± 3.43 5.38 ± 0.95 5.92 ± 1.12 5.52 ± 1.14 5.86 ± 1.11 6.12 ± 1.05 6.47 ± 1.12 
DLPFC 3.87 ± 1.77 3.89 ± 1.96 3.77 ± 1.87 3.80 ± 2.06 4.70 ± 1.91 4.92 ± 2.17 3.92 ± 1.10 3.79 ± 0.61 3.78 ± 1.07 3.64 ± 0.70 4.34 ± 0.94 4.48 ± 0.87 
Ant. Lat. 
Temporal 
lobe 5.25 ± 1.37 5.81 ± 2.23 5.09 ± 1.55 5.47 ± 2.39 7.58 ± 2.92 7.36 ± 1.98 5.52 ± 1.12 5.93 ± 1.27 5.37 ± 1.36 5.62 ± 1.02 5.97 ± 1.17 6.18 ± 1.02 
Medial 
Temporal 4.58 ± 2.35 5.04 ± 2.71 4.88 ± 1.98 4.98 ± 2.64 4.97 ± 2.69 5.20 ± 2.57 4.61 ± 1.85 5.42 ± 1.25 4.48 ± 1.65 5.38 ± 1.36 5.58 ± 2.30 6.15 ± 1.90 
Average 4.47 4.53 4.49 4.46 5.57 5.49 4.58 4.91 4.54 4.79 5.51 5.65 
  SABRE 
  Patients Comparison Subjects 
 S1A S1B S2 S1A S1B S2 
  Lt Rt Lt Rt Lt Rt Lt Rt Lt Rt Lt Rt 
Frontal lobe 4.09 ± 1.68 3.83 ± 1.79 3.85 ± 2.27 3.61 ± 2.36 3.99 ± 1.60 3.71 ± 1.77 4.67 ± 1.29 4.58 ± 1.24 4.55 ± 1.00 4.47 ± 0.94 4.49 ± 1.14 4.43 ± 1.10 
OFC 4.07 ± 2.57 3.54 ± 2.73 3.91 ± 3.06 3.45 ± 3.18 4.01 ± 2.59 3.26 ± 2.94 5.50 ± 1.01 4.86 ± 1.03 5.57 ± 0.83 5.03 ± 0.98 5.23 ± 0.86 5.19 ± 1.39 
DLPFC 4.04 ± 1.46 3.90 ± 1.48 3.78 ± 2.04 3.62 ± 2.04 4.73 ± 1.44 4.09 ± 1.54 4.27 ± 1.30 4.34 ± 1.01 4.32 ± 1.19 4.44 ± 0.96 5.61 ± 2.91 5.96 ± 2.94 
Ant. Lat. 
Temporal 
lobe 5.07 ± 1.63 5.06 ± 1.61 4.74 ± 2.16 4.74 ± 2.22 4.89 ± 1.44 4.90 ± 1.50 5.42 ± 1.37 5.36 ± 1.28 5.25 ± 1.02 5.18 ± 0.89 5.27 ± 1.21 5.10 ± 1.05 
Medial 
Temporal 5.32 ± 3.19 5.82 ± 1.98 5.61 ± 2.49 5.39 ± 2.44 5.68 ± 1.89 5.62 ± 1.83 5.95 ± 1.13 5.85 ± 0.64 6.11 ± 0.89 6.14 ± 0.66 9.19 ± 1.16 6.00 ± 0.90 
Average 4.52 4.43 4.38 4.16 4.59 4.31 5.16 5.00 5.16 5.05 5.36 5.34 
             
§ indicates 
average ± 
SD             
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Table 2. Correlations between 5-HT1aR BP values from manual versus SABRE ROI analysis 
(Spearman rs values) were statistically significant (p < .05) except where noted. 
 
 S1A vs M1A S1A vs M1B S1A vs M2  
Row 
Average 
 Lt Rt Lt Rt Lt Rt  Lt Rt 
Frontal lobe 
0.80 0.93 0.90 0.88 0.75 0.97 
 
0.82 0.93 
OFC 
0.82 0.93 0.83 0.93 0.78 0.87 
 
0.81 0.91 
DLPFC 
0.87 0.88 0.88 0.78 0.85 0.67 
 
0.87 0.78 
Ant. Lat. Temporal 
lobe 0.95 0.90 0.93 0.82 0.63 0.67 
 
0.84 0.79 
Medial Temporal 
0.58 0.85 0.60 0.80 0.68 0.52?   0.62 0.72 
Column Average 
0.80 0.90 0.83 0.84 0.74 0.74 
 
0.79 0.83 
 S1B vs M1A S1B vs M1B S1B vs M2    
 Lt Rt Lt Rt Lt Rt    
Frontal lobe 
0.82 0.90 0.95 0.85 0.75 0.95 
 
0.84 0.90 
OFC 
0.82 0.80 0.83 0.80 0.78 0.88 
 
0.81 0.83 
DLPFC 
0.92 0.85 0.93 0.85 0.88 0.78 
 
0.91 0.83 
Ant. Lat. Temporal 
lobe 0.90 0.95 0.88 0.87 0.70 0.53?   0.83 0.78 
Medial Temporal 0.42?  0.85 0.33?  0.83 0.50?  0.72  0.42 0.80 
Column Average 
0.77 0.87 0.79 0.84 0.72 0.77 
 
0.76 0.83 
 S2 vs M1A S2 vs M1B S2 vs M2    
 Lt Rt Lt Rt Lt Rt    
Frontal lobe 
0.80 0.93 0.90 0.88 0.75 0.97 
 
0.82 0.93 
OFC 
0.97 0.80 0.98 0.80 0.93 0.88 
 
0.96 0.83 
DLPFC 
0.88 0.72 0.78 0.72 0.83 0.92 
 
0.83 0.78 
Ant. Lat. Temporal 
lobe 0.98 0.95 0.92 0.92 0.65 0.43?   0.85 0.77 
Medial Temporal 0.37?  0.85 0.33?  0.83 0.47?  0.72  0.39 0.80 
Column Average 
0.80 0.85 0.78 0.83 0.73 0.78 
 
0.77 0.82 
 
?  indicates p value for correlation between manual and SABRE analysis > .05
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Table 3. Summary of average left-right ratios of 5-HT1aR BP values 
 
 Manual 
 M1A M1B M2 
Frontal lobe 1.02 1.03 1.06 
OFC 1.31 1.37 1.10† 
DLPFC 1.04 1.04 0.97 
Ant Lat Temporal 
Lobe 
0.94 0.97 0.95 
Medial Temporal 0.91 0.97 0.92 
  SABRE  
 S1A S1B S2 
Frontal lobe 1.04 1.04 1.06 
OFC 1.22 1.32 2.96 
DLPFC 1.02 1.02 1.03 
Ant Lat Temporal 
Lobe 
1.01 1.01 1.01 
Medial Temporal 0.90 1.02 1.02 
 
OFC = orbitofrontal cortex, DLPFC = dorsolateral prefrontal cortex, Ant Lat Temporal 
Lobe = anterior lateral temporal lobe 
†
 
 Wilcoxon p < 0.05 vs. S1A 
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Table 4. Intra-rater reliability of intra-class correlation coefficients and repeatability coefficients 
?  
 Manual (M1A-M1B) 
 Lt  Rt 
 ICC RC RM %  ICC RC RM % 
Frontal lobe 0.99 
0.46 6.33 
 1.00 
0.43 6.02 
OFC 1.00 
0.73 6.92 
 1.00 
0.86 7.51 
DLPFC 1.00 
0.68 6.58 
 0.99 
0.43 4.31 
Ant Lat Temporal 
lobe 
0.98 
0.35 4.52 
 0.98 
0.46 6.11 
Medial Temporal 0.98 
1.09 11.74 
 1.00 
0.34 3.31 
Average 0.99 
0.66 7.22 
 0.99 
0.51 5.45 
 SABRE (S1A – S1B) 
 Lt  Rt 
 ICC RC RM %  ICC RC RM % 
Frontal lobe 0.99 
1.07 12.57 
 1.00 
1.03 12.57 
OFC 1.00 
0.91 9.75 
 1.00 
0.87 10.45 
DLPFC 0.99 
1.15 14.12 
 1.00 
1.23 15.25 
Ant Lat Temporal 
lobe 
0.99 
1.27 12.46 
 0.99 
1.38 13.60 
Medial Temporal 0.99 
2.38 20.82 
 0.99 
1.85 16.01 
Average 0.99 
1.36* 13.94* 
 0.99 
1.27* 13.58* 
 
 
OFC = orbitofrontal cortex, DLPFC = dorsolateral prefrontal cortex, Ant Lat Temporal 
Lobe = anterior lateral temporal lobe 
* p = 0.043 vs. manual results, Wilcoxon rank test 
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Table 5. Inter-rater reliability intra-class correlation coefficients  
 Manual 
 M1A vs M2  M1B vs M2 
 Lt Rt  Lt Rt 
Frontal lobe 0.94 0.96  0.93 0.96 
OFC 0.96 0.95  0.96 0.95 
DLPFC 0.95 0.97  0.95 0.97 
Ant Lat Temporal 
Lobe 
0.50 0.62  0.57 0.67 
Medial Temporal 0.98 0.98  0.94 0.99 
Average 
0.87 0.90 
 
0.87 0.91 
 SABRE 
 S1A vs S2  S1B vs S2 
 Lt Rt  Lt Rt 
Frontal lobe 
0.99 1 
 
0.96 0.97 
OFC 
0.99 0.98 
 
0.98 0.99 
DLPFC 
0.69 0.65 
 
0.97 0.78 
Ant Lat Temporal 
Lobe 0.99 0.98 
 
0.95 0.94 
Medial Temporal 
0.92 0.96 
 
0.97 0.94 
Average 
0.92 0.91 
 
0.97 0.92 
 
OFC = orbitofrontal cortex, DLPFC = dorsolateral prefrontal cortex, Ant Lat Temporal Lobe = 
anterior lateral temporal lobe
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Table 6. Cohen’s measure for effect size using manual versus SABRE analysis to differentiate 
FTD from controls 
 Manual 
 M1A  M1B  M2 
 Lt Rt  Lt Rt  Lt Rt 
Frontal lobe 0.11 0.08  0.19 0.18  -0.32 -0.01 
OFC -0.15 -0.58  -0.25 -0.54  -0.24 -0.64 
DLPFC -0.04 0.08  -0.01 0.12  0.25 0.29 
Ant Lat Temporal Lobe -0.22 -0.06  -0.20 -0.09  0.74 0.71 
Medial Temporal -0.01 -0.19  0.22 -0.20  -0.24 -0.42 
Average -0.06 -0.13  -0.01 -0.11  -0.26 -0.30 
 SABRE 
 S1A  S1B  S2 
 Lt Rt  Lt Rt  Lt Rt 
Frontal lobe -0.39 -0.49  -0.43 -0.52  -0.37 -0.50 
OFC -0.80 -0.70  -0.85 -0.76  -0.71 -0.89 
DLPFC -0.17 -0.36  -0.34 -0.54  -0.57 -0.84 
Ant Lat Temporal Lobe -0.24 -0.20  -0.32 -0.28  -0.29 -0.15 
Medial Temporal -0.29 -0.02  -0.29 -0.49  -0.33 -0.28 
Average -0.38* -0.35  -0.45* -0.52†  -0.45* -0.53† 
 
OFC = orbitofrontal cortex, DLPFC = dorsolateral prefrontal cortex, Ant Lat Temporal 
Lobe = anterior lateral temporal lobe 
* p < 0.05 vs. left M1A & M1B 
†
 
p < 0.05 vs. right M1A & M1B 
Chow, TW et al 
                                      Page 30 of 30  
Additional Files 
File name: Appendix I 
File format: Microsoft Word Document (.doc) 
Title of data: Appendix I. Summary of ROI definition for manual drawing 
Description of data: Landmark definitions for hand-drawing of manual ROIs on 
the co-registered T1 images using the Alice software (Perceptive Informatics, 
Waltham, Massachusetts) 
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